Elevance Health Q3 Adj. EPS $6.99 Beats $4.68 Estimate, Sales $50.440B Beat $49.213B Estimate

Elevance Health (NYSE: ELV) reported Q3 adjusted earnings per share of $6.99, surpassing the analyst estimate of $4.68 by 49.36%, and reflecting a 15.92% increase from $6.03 in the same quarter last year. The company's quarterly sales reached $50.440 billion, exceeding the expected $49.213 billion by 2.49%, and showing a slight 0.70% increase from $50.087 billion in the previous year.